Autophagy is an intracellular lysosomal degradative pathway important for tumor 2 4 surveillance. Autophagy deficiency can lead to tumorigenesis. Autophagy is also known to be 2 5 important for the aggressive growth of tumors, yet the mechanism that sustains the growth of 2 6 autophagy-deficient tumors is not known. We previously reported that progression of hepatic 2 7 tumors developed in autophagy-deficient livers required high mobility group box 1 (HMGB1) 2 8 that is released from autophagy-deficient hepatocytes. However, the mechanism by which 2 9 HMGB1 promotes hepatic tumorigenesis is not understood. In this study we examined the 3 0 pathological features of the hepatic tumors and the mechanism of HMGB1-mediated 3 1 tumorigenesis using liver-specific autophagy-deficient (Atg7-/-) and Atg7-/-/Hmgb1-/-mice. We 3 2 found that in Atg7-/-mice the tumors cells were still deficient in autophagy and could also 3 3 release HMGB1. Histological analysis using cell-specific markers suggested that fibroblast and 3 4 ductular cells were present only outside the tumor whereas macrophages were present both 3 5 inside and outside the tumor. Genetic deletion of HMGB1 or one of its receptors, receptor for 3 6 advanced glycated end product (Rage), retarded liver tumor development. In addition, we found 3 7 that expression of RAGE was only on ductual cells and Kupffer's cells but not on hepatoctyes, 3 8 which suggested that HMGB1 might promote hepatic tumor growth through a paracrine mode 3 9 that altered the tumor microenvironment. Furthermore, HMGB1 and RAGE enhanced the 4 0 proliferation capability of the autophagy-deficient hepatocytes and tumors. Finally, RNAseq 4 1 analysis of the tumors indicated that HMGB1 induced a much broad changes in tumors. In 4 2 particular, genes related to mitochondrial structures or functions were enriched among those 4 3 differentially expressed in tumors in the presence or absence of HMGB1, revealing a potential 4 4 7 1 codeletion of Hmgb1 in the autophagy-deficient liver results in delayed tumor development via a 7 2 mechanism independent of its usual role in injury, inflammation, and fibrosis 2 .It is thus unclear 7 3 how HMGB1 mechanistically promotes hepatic tumorigenesis in autophagy-deficient liver. 7 4
hepatocytes. We further confirmed this notion by examining the expression of SQSTM1 and 1 0 1 ubiquitin(UB) in the liver. Immunohistological and immunofluorescence analysis was performed 1 0 2 by taking images of eight different regions covering the non-tumor, peri-tumor, and the tumor 1 0 3 regions as shown in Figure 1B . A clear accumulation of SQSTM1 and UB in the tumor region of 1 0 4 the autophagy-deficient liver was observed, which was at the level similar to that in the non-1 0 5 tumor tissues ( Figure 1C-D) , suggesting that the tumor tissues were defective in autophagy and 1 0 6 had defective protein quality control. In addition, the tumor tissues were all positive for the 1 0 7 hepatocyte-specific marker, HNF4α, which were colocalized in the same cells that had elevated 1 0 8 SQSTM1 and UB staining ( Figure 1F ). We next analyzed whether the accumulation of SQSTM1 in tumor tissue could activate 1 1 0 the anti-oxidative response-related NRF2 transcription factor as in non-tumor tissues 1,9 . We 1 1 1 found that one NRF2 target protein, NQO1, were drastically elevated in the tumor tissues of the 1 1 2 Atg7-/-mice ( Figure 1A) . The mRNA level of the NRF2 target genes, Nqo1 and Gstm1 were 1 1 3 also significantly elevated in the Atg7-/-samples whether they were from non-tumor or tumor 1 1 4 tissue (Figure 1G) . These observations indicated that hepatic tumors in autophagy-deficient 1 1 5 livers arise from the autophagy-deficient hepatocytes with alterned NRF2 and SQSTM1 levels. Hepatic progenitor cells(HPC), also known as oval cells or ductular cells, expand during 1 2 0 chronic liver injury in patients and in rodents 11, 12 . The expansion of HPCs is significant in the 1 2 1 autophagy-deficient livers 2 . HPC has been noted to possess the capacity to become tumorigenic 1 2 2 in vivo when transduced with H-ras and SV40LT 13 . We thus explored the relationship of these 1 2 3 cells to the tumor in autophagy-deficient livers by examining their spatial interactions. H-E staining showed that the distribution of HPCs was mostly around the tumor-adjacent 1 2 5 region (Figure 2A) . In the area of tumor tissues, the normal tissue architecture, such as bile duct, 1 2 6 and portal tract formation, was completely lost. Moreover, the tumor region was composed of 1 2 7 irregular hepatic plates with tumor cells showing large nuclear-cytoplasmic ratio and 1 2 8 occasionally nuclear atypia (Figure 2A) . Immunostaining for CK19, a common marker for 1 2 9 expanded HPC showed that the hepatic tumors were negative for CK19 ( Figure 2B) . Instead, the HPCs were positive for SQSTM1 aggregates although many did not show elevated 1 3 4 Figure S1A-B) . The possibility that some of this SQSTM1 positive 1 3 5 HPC may be derived from the autophagy-deficient hepatocytes cannot be excluded as such 1 3 6 transdifferentiation had been reported previously 11, 14 . Interestingly, HPC and liver cancer stem cells (CSC) also share several cellular markers 1 3 8 15 . Markers such as EpCAM, CD133, and CD24 have been used for isolating CSC with stem cell 1 3 9
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features 15, 16 . HPC in the context of chronic liver injury has also been considered as one possible 1 4 0 origin of liver CSC. We thus analyzed the expression of these CSC markers in the non-tumor and 1 4 1 tumor tissues of the autophagy-deficient liver. Real-time PCR analysis showed that the 1 4 2 expression of Cd133, Cd200, Cd34, Cd44, Ly6a/Sca1, and Ly6d were significantly upregulated 1 4 3 in Atg7-/-liver tissues compared to control Atg7 F/F mice (Supplementary Figure S2A) . The 1 4 4 elevation of these CSC markers in the tumor tissues also suggested that tumors have a 1 4 5 precursor/stem-cell phenotype. Such induction was not observed with Cd24a, and Cd90, 1 4 6 suggesting the possible heterogeneity in the CSC in the tumor and non-tumor tissues of Atg7-/-1 4 7 mice (Supplementary Figure S2A) . Interestingly, most of the stemness-related transcription 1 4 8 factors such as Oct4, Nanog, Klf4 and Sox2 were significantly downregulated in Atg7-/-livers as 1 4 9 compared to Atg7F/F livers (Supplementary Figure S2B) . The lack of expression of Nanog has 1 5 0 been linked to the adenoma nature of the tumor 17 . These changes were not more significant in 1 5 1 the tumor tissue than in the non-tumor tissues, and thus may not be the mechanisms 1 5
To determine whether HMGB1 released by the autophagy-deficient hepatocytes or 3 1 1 hepatic tumor cells could act as an autocrine fashion to promote cellular proliferation, we 3 1 2 examined whether hepatoctyes could express RAGE. Immunofluorescence staining was 3 1 3 performed in frozen tissue from Atg7 F/F and Atg7-/-liver. We found that RAGE was almost 3 1 4 exclusively expressed by cells other than hepatocytes based on cell morphology, but it was 3 1 5 detected on the cell surface, consistent with its being a receptor molecule (Figure 7A) (for stellate cells), was conducted. Colocalization of RAGE was evident in CK19 or SOX9- These findings indicate that RAGE was expressed on ductular cells and Kupffer cells but 3 2 2 not on hepatocytes nor stellate cells. Futhermore, these observations suggest that unlike the expressing cells, such as the Kupffer's cells, which could then alter the microenvironment that 3 2 7 facilitate tumor development. Since the effect of HMGB1 in promoting tumor development may be mediated by an 3 3 2 altered microenvironment, there could be multiple alterations in tumor behaviors affected by this 3 3 3 process. We sought to investigate the transcriptomic profile of the tumor to better understand the 3 3 4 impact of HMGB1 on tumor development in autophagy-deficient livers. We chose to perform 3 3 5
RNA sequencing on tumor tissues obtained from Atg7-/-and Atg7-/-/Hmgb1-/-mice at the age of 3 3 6 15 months old, when the tumor number and size were comparable in these mice. The principal component analysis (PCA) on the RNAseq data indicated different when compared with the non-tumor tissues ( Figure 8A) , The six non-tumor samples from the 3 4 0 two strains of mice were close to each other. In addition, two out of the three tumor samples from Atg7-/-mice were separated the farthest from the rest of the samples. PCA thus suggests 3 4 3 that tumors from the two strains of mice were quite different with those from Atg7-/-/Hmgb1-/-3 4 4 livers more similar to the non-tumor tissues in their transcriptomic profiles. Differential expression analysis showed that 284 and 372 differentially expressed genes 3 4 6 (DEGs) were upregulated in tumors of Atg7-/-and Atg7-/-/Hmgb1-/-livers, respectively, 3 4 7 whereas 326 and 300 genes were downregulated in tumors of these livers, respectively ( Figure   3 4 8 8B-C). A complete list of these DEGs can be found in Supplementary Tables S1-S5. We then 3 4 9 focused on discovering unique molecular features in the tumous associated with the presence and number of up-regulated (28, Figure 8B ) or down-regulated (12, Figure 8C ) DRGs were found in To understand the molecular features of these differences, we determined the Gene Ontology (GO) terms and KEGG pathways that were significantly enriched in the unique DEG sets. We found that many biological processes, particularly those associated with mitochondrial in Atg7-/-tumors ( Figure 8D) . Notably, DEGs down-regulated uniquely in Atg7-/-/Hmgb1-/-3 6 0 tumors were also enriched for those involved in the mitochondrial structures or functions, function and activity, which may impact the celluar bioenergetics and hence tumor growth in 3 6 8 autophagy-deficient liver. hepatic autophagy, such as that caused by the liver-specific deletion of Atg5 or Atg7, leads to aggressive growth of tumors. The mechanism that sustains the growth of autophagy-deficient tumors is not known. In this study, we examined the cellular and molecular nature of hepatic 3 7 5 tumors in the autophagy-deficient liver. Our findings support the following conclusions: 1) The have significantly different transcriptomic profiles and mitochondria function could be an 3 8 0 important mechanistic linker to tumor promotion. further showed that tumor cells were originated from the autophagy-deficient hepatocytes. The composition of the tumor appears to be different from the non-tumor liver tissue. In the tumor cells (HNF4α positive), and some macrophages (Figure 1-3 Table   3 9 0 S6). Other nonparenchymal cells are found only outside the tumor region. Fibrotic cells and 3 9 1 ductular cells seem to be responsible for the formation of a fibrous capsule that demarcates the 3 9 2 tumor from the non-tumor tissue. How the autophagy-deficient hepatocytes form the 3 9 3 adenomatous nodule, excluding the fibrotic cells and ductular cells but retaining some 3 9 4 macrophages, is intriguing. But macrophages could belong to those known as tumor-associated 3 9 5 macrophages(TAM) and may enter into the tumor tissue via tumor blood vessels 37 . HMGB1 is known to promote tumor development 2,38,39 . However, how HMGB1 does 3 9 7 this, in particular for the autophagy-deficient heaptic tumors, is not clear. HMGB1 has been 3 9 8
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shown to be important for expansion of ductular cells 2,38 , , immune cells recruitment 25 and 3 9 9 activation of fibrotic cells 24 . All these cellular events could favor tumorigenesis. Previously, we 4 0 0 showed that non-tumorigenic autophagy-deficient hepatocytes can release HMGB1 2 . Here our 4 0 1 findings indicate that HMGB1 could be also released by the autophagy-deficient hepatic tumor 4 0 2 cells. Thus HMGB1 may act through an autocrine or paracrine mode to promote tumor growth.
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We found that the proliferative effect of HMGB1 could be mediated via the RAGE However, it seems that some of the well-defined proinflammatory cytokines such as TNFα, IL-4 1 5 1β, and IL-6 may not play the role as the expression of these cytokines are remarkably 4 1 6 downregulated in tumor tissues of Atg7-/-mice (Supplementary Figure S4) . On the other hand, The Rage deletion could not fully protect the Atg7-/-mice from tumor development at inhibit tumor development in Atg7-/-mice even at the 12-month time point (Figure 6A-B possible that HMGB1 affect the tumorigenesis process not only via RAGE but also through other 4 2 7 receptors such as TLR4 36 . Future studies can assess the potential role of TLR4 in this process. growth of tumors that are derived from these cells. /-tumors is unclear. But it is well known that mitochondrial ETC enables many metabolic 4 4 1 processes and is a major sources of ATP and building blocks for the proliferation of tumor cells. As a consequence of ETC dysfunction, cell proliferation could be impaired due to bioenergetics of ETC caused impaired cell proliferation of cells in vitro 42, 43 . Interestingly, a recent study 1 suggest that ETC enables aspartate biosynthesis, a key proteogenic amino acid that is also a 4 4 6 precursor in purine and pyrimide synthesis and is required for tumor cells growth and survival In conclusion, our findings demonstrate that hepatic adenoma originates from the 4 5 5
autophagy-deficient hepatocytes that release HMGB1. HMGB1, in turn, can stimulate 4 5 6
hepatocyte proliferation and hepatic tumorigenesis via RAGE in the autophagy-deficient liver. The effect of HMGB1 on tumor cells are broad as revealed by transcriptomic analysis, which 4 5 8 offers mechanistic clues for future studies. Rage-/-mice were used in this study. Atg7F/F was obtained from Dr. Komatsu Masaaki (Nigata
University, Japan). These mice were backcrossed with C57BL/6J for another 10 generations as Harbor, ME). Hmgb1 F/F and Rage mice were as described 2 . Hepatic Atg7-/-mice were further Immunoblot analysis was performed as described previouosly 2,20 using primary 4 8 9
antibodies and respective secondary antibodies conjugated with horseradish peroxidase as listed
in Supplementary Table S8 . The respective protein bands were visualized using the 4 9 1
immunobilion chemiluminescence system (Millipore, MA). The densitometry analysis of 4 9 2
immunoblotting images was performed using Quantity One Software (Bio-rad). Densitometry RNA was isolated from liver tissues using a GeneTET RNA Purification Kit (Thermo Fisher 4 9 8
Scientific) according to the manufacturer's protocol. cDNA was synthesized using an M-MLV 4 9 9
Reverse Transcriptase Enzyme System (Life Technologies, Thermo Fisher Scientific) and OligodT primers. The resulting cDNA products were subjected to qPCR reaction using SYBR the forward and reverse primers are listed in Supplementary Table S7 . RNA-sequencing and bioinformatics analysis: RNA was isolated as described above. RNAseq all high-quality sequences were mapped to the mouse genome (mm10, UCSC Genome Browser, 5 1 8
https://genome.ucsc.edu/) with the STAR, an RNA-seq aligner 46 . The featureCounts was adopted 5 1 9
to assign uniquely mapped reads to genes according to UCSC refGene (mm10) 47 . Those low-
expressed genes were not further analyzed if their raw counts were less than 10 in more than multiple-test false discovery rate (FDR) correction were determined as differentially expressed were expressed as Mean±SE. Student t-test was performed to compare values from two groups.
3 1
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